USPTO trademark

ADLIZA

Under examinationUSPTOWord markClass 5

"ADLIZA" is a word mark owned by Definium Therapeutics US, Inc., filed at the USPTO on August 28, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
ADLIZA trademark as filed
As filed with the USPTO
Status
Under examination
Since August 28, 2026
Filed
August 28, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50077884
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ADLIZA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services ADLIZA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About ADLIZA

Who owns the trademark "ADLIZA"?

The USPTO trademark "ADLIZA" (application 50077884) is owned by Definium Therapeutics US, Inc.

What is the status of "ADLIZA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ADLIZA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a04da7-41c5-7695-8bfb-22ccf86b99b2
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a04da7-41c5-7695-8bfb-22ccf86b99b2",
  "object": "trademark",
  "mark_text": "ADLIZA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50077884",
  "filing_date": "2026-08-28",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Definium Therapeutics US, Inc.",
      "entity_id": "ent_019ebc04-c269-749f-a16a-16a0f0191bdd"
    }
  ]
}